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Abstract
Background: Growing interest in multimorbidity is observable in industrialized countries. For Germany, the
increasing attention still goes still hand in hand with a small number of studies on multimorbidity. The authors
report the first results of a cross-sectional study on a large sample of policy holders (n = 123,224) of a statutory
health insurance company operating nationwide. This is the first comprehensive study addressing multimorbidity
on the basis of German claims data. The main research question was to find out which chronic diseases and
disease combinations are specific to multimorbidity in the elderly.
Methods: The study is based on the claims data of all insured policy holders aged 65 and older (n = 123,224).
Adjustment for age and gender was performed for the German population in 2004. A person was defined as
multimorbid if she/he had at least 3 diagnoses out of a list of 46 chronic conditions in three or more quarters
within the one-year observation period. Prevalences and risk-ratios were calculated for the multimorbid and
non-multimorbid samples in order to identify diagnoses more specific to multimorbidity and to detect excess
prevalences of multimorbidity patterns.
Results: 62% of the sample was multimorbid. Women in general and patients receiving statutory nursing care due
to disability are overrepresented in the multimorbid sample. Out of the possible 15,180 combinations of three
chronic conditions, 15,024 (99%) were found in the database. Regardless of this wide variety of combinations, the
most prevalent individual chronic conditions do also dominate the combinations: Triads of the six most prevalent
individual chronic conditions (hypertension, lipid metabolism disorders, chronic low back pain, diabetes mellitus,
osteoarthritis and chronic ischemic heart disease) span the disease spectrum of 42% of the multimorbid sample.
Gender differences were minor. Observed-to-expected ratios were highest when purine/pyrimidine metabolism
disorders/gout and osteoarthritis were part of the multimorbidity patterns.
Conclusions: The above list of dominating chronic conditions and their combinations could present a pragmatic
start for the development of needed guidelines related to multimorbidity.
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Background
Driven by increasing longevity and the rise of healthcare
costs, a growing interest in multimorbidity is observable
in industrialized countries [1]. Still, there is a far smaller
number of studies on multimorbidity than on individual
chronic diseases [2]. Pioneering work on multimorbidity
has been done in a few countries, in particular Australia
[3,4], Canada [5,6], The Netherlands [7,8], and Sweden
[9,10]. All studies demonstrate a high prevalence of
chronic diseases especially among the elderly. However,
they differ largely with regard to the figures on preva-
lence and the number of chronic diseases. For example,
in a literature review published in 2005, Fortin et al.
found rates of multimorbidity in the elderly of 49% to
99% and an average number of chronic diseases per per-
son between 2.5 and 6.5 [5]. Most studies also show a
strong association between the degree of multimorbidity
and its impact on patients, e.g. on mortality, functional
status and quality of life [6,11,12]. The broad range of
prevalences in studies is due to differences in study
design and the chronic conditions included. For exam-
ple, mental comorbidity is often not investigated,
although it is frequently associated with somatic
morbidity [12-14].
This growing interest in multimorbidity contrasts with
the small number of studies in Germany too. Since
2008, the Federal Ministry of Education and Research
has been supporting six research networks studying
health in the elderly, in which multimorbidity is an
important topic [15]. This paper reports the concept
and the first results of a study on multimorbidity in the
elderly (65 years and older) using routine claims data
from a German statutory health insurance company.
The aim of the study was to explore the field of multi-
morbidity for Germany and to develop strategies for
further investigations, as this was the first systematic
study on multimorbidity in the elderly in Germany.
Methods
The basis for the analysis are the claims data of the
Gmünder ErsatzKasse (GEK), a statutory health insur-
ance company operating nationwide in Germany and
insuring some 1.7 million persons, a figure correspond-
ing to some 2.4% of the statutorily insured population.
The data were provided by GEK-Insurance in a pseu-
donymous form.
Originally, the GEK insured mainly craftsmen, and
therefore the proportion of insured men exceeds that of
women even today. Previous studies have shown that
results from the GEK database can be transferred to the
German population as a whole, if adjusted for age and
gender [16]. For this study, adjustment was performed
for age and gender for the general German population
according to data from the Federal Bureau of Statistics
as of December 31, 2004. The adjustment procedure
and its results are shown in Additional File 1.
The claims data stem from physicians in the ambula-
tory care setting only. Claims are forwarded on a quar-
terly basis by the individual physician to the association
of statutory health insurance physicians, where they are
checked for comprehensiveness and plausibility. There-
after, the data are transmitted to the statutory insurance
companies. According to German law, physicians in the
ambulatory care setting [they are not receiving care]
must note all ICD-10 codes relevant to the current
treatment of the individual patient in the electronic
claim document. Since elderly multimorbid patients visit
physician premises in ambulatory care with an average
frequency of 36 contacts per year, the registration of
morbidity by physicians in this study is most likely not
impeded by a lack of contacts.
We selected the most frequent conditions in GP sur-
geries as published in a panel survey ("ADT Panel”) of
the Central Research Institute of Statutory Ambulatory
Health Care in Germany [17,18]. Chronicity of diag-
noses was assessed using the “Expert Report for the
Selection of 50 to 80 Diseases to be Included in the
Morbidity Based Risk Adjustment Scheme”, published in
2007 [19]. In order to capture a comprehensive picture
of the disease patterns in individual patients we
amended this list for all chronic conditions with a pre-
valence ≥ 1% in the age group ≥ 65 years found in the
GEK data set of from 2006. The ICD-10 codes for
chronic conditions were grouped by an expert panel of
family physicians from the Hamburg Institute of Pri-
mary Medical Care in order to account for coding var-
iance among physicians for the same syndrome. For
example, F00-F03, F05.1, G30, G31 and R54 were
grouped under the heading “dementia”. The result of
this procedure was a list of 46 single codes and code
groups further referred to as “chronic conditions” in this
paper. This list includes all frequent somatic and psychic
disorders (see Additional File 2).
A person was defined as chronically ill if she/he had at
least one of the 46 chronic conditions in at least three
quarters within the one-year observation period of 2004.
The three-quarters criterion was chosen in order to
avoid transitory or erroneous diagnoses, a usual proce-
dure when using health insurance claims data for
research in Germany. Also, acute or subacute forms of
certain conditions were excluded by using this criterion.
Among the chronically ill, a person was considered to
be multimorbid when he/she had three or more chronic
conditions from the list. The criterion of three chronic
conditions was considered to be a more valid cut-off
score for multimorbidity in elderly patients treated in
the ambulatory care setting, instead of the usual criter-
ion of two chronic conditions [20], which would
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frequently lead to very high rates of multimorbidity in
the age group over 65 years. Recent research supports
using the criterion of ≥ 3 conditions for investigations
of multimorbidity in the ambulatory care setting [8,21],
especially when the aim is to compare multimorbid and
non-multimorbid samples in the total cohort.
In our study, adjusted prevalences were calculated
separately for the total cohort as well as for the multi-
morbid sample (abbreviated as mm-sample) and the
non-multimorbid sample (abbreviated as nmm-sample).
Furthermore, relative risks (or risk ratios; abbreviated
RR) were calculated for individual chronic conditions.
The relative risk expresses the likelihood of a chronic
condition to be associated with multimorbidity (under
consideration of the prevalence of the condition) or - in
other words - the likelihood of multimorbid persons suf-
fering from a specific chronic condition in comparison
to non-multimorbid persons. Due to somewhat high
prevalence of several chronic conditions, we preferred
the estimation of relative risks over odds ratios [22].
Observed-to-expected ratios (O/E ratio) were calculated
in order to estimate conditional probabilities of combi-
nations of three chronic conditions. All analyses were
performed using the statistics packages SAS (version
9.2) and R (version 2.11.1). The study was approved by
the Ethics Committee of the Medical Association of
Hamburg.
Results
The cohort consisted of 123,224 patients aged 65 years
and older. Sociodemographic characteristics of the total
cohort and of both the mm-sample and the nmm-
sample after adjustment for the German population in
2004 are presented in Table 1.
Persons in the mm-sample were on average 2.6 years
older than those in the nmm-sample. Women were
overrepresented among the multimorbid (61.5% vs.
55.3% in the nmm-sample) and were older than men in
both samples (2.3 years older in the mm- and 2.1 years
in the nmm-sample). The percentage of patients receiv-
ing services from the statutory nursing insurance
scheme due to disability was almost 100% higher among
the multimorbid than among the non-multimorbid.
62.1% of the cohort was multimorbid in the sense of
presenting ≥ 3 chronic conditions from the 46-item list
(see Figure 1). With a criterion of ≥ 2 chronic conditions
this percentage would have risen to 73%. Even with a cri-
terion of ≥ 4 chronic conditions, nearly half (49%) of the
sample would have been defined as multimorbid.
The median of chronic conditions in the mm-sample
was 5, compared to 1 in the nmm-sample. Gender dif-
ferences with regard to the number of chronic condi-
tions in the mm-sample (5.7 for males and 5.9 for
females) were small but statistically significant (p <
0.001). In the nmm-sample, nearly half (48.8%) had no
chronic condition of the list whereas the other half had
1 (22.6%) or 2 (28.6%).
As expected, the number of chronic conditions increased
with age in the mm-sample (Figure 2). However, the differ-
ence in the number of chronic conditions between the
youngest and the oldest age-group was only 1, although
the difference in average age between the youngest and the
oldest age group was 17 years.
Prevalence of individual chronic conditions
Hypertension was by far the most frequent chronic condi-
tion in both samples (65.4% in the mm-sample and 17.9%
in the nmm-sample). Lipid metabolism disorders (42.9%)
Table 1 Sociodemographic characteristics of the total cohort, the multimorbid and non-multimorbid samples (adjusted
for the German population 2004)
Total cohort Multimorbid sample Non-multimorbid sample p*
Number of persons 123,224 76,540 46,684
% 100.0% 62.1% 37.9%
Mean Age all (SD) 74.1 (7.1) 75.1 (7.2) 72.5 (6.7) < 0.001
Mean age men (SD) 72.7 (6.4) 73.7 (6.5) 71.3 (5.9) < 0.001
Mean age women (SD) 75.1 (7.5) 76.0 (7.5) 73.4 (7.2) < 0.001
Gender (% females) 59.2% 61.5% 55.3% < 0.001
Average number of chronic conditions (SD) 3.9 (3.2) 5.8 (2.6) 0.8 (0.9) < 0.001
Mean number men (SD) 3.6 (3.1) 5.7 (2.5) 0.7 (0.8) < 0.001
Mean number women (SD) 4.1 (3.2) 5.9 (2.6) 0.8 (0.9) < 0.001
Nursing care dependency all (% receiving services) 19.1% 23.2% 12.3%
% males 14.2% 18.0% 8.8% < 0.001
% females 22.4% 26.5% 15.1% < 0.001
SD = standard deviation;
p* = statistical significance of the difference between the multimorbid and the non-multimorbid sample (t-tests were performed for comparison of means, and
chi-square-tests for differences between percentages).
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and chronic low back pain (41.2%) were also very frequent
among multimorbid patients. A prevalence slightly below
30% was found for osteoarthritis (29.5%), diabetes mellitus
(28.5%), and chronic ischemic heart disease (27.5%),
whereas severe vision reduction (21.5%) and thyroid dys-
function (21.4%) had a prevalence slightly over 20% in the
mm-sample. In total, 21 of the 46 chronic conditions had a
prevalence of > 10% in the mm-sample. Adjusted preva-
lence, prevalence rank order, and relative risk for multimor-
bidity of the 46 chronic conditions in the multimorbid and
non-multimorbid sample are presented in Additional File 3
(for the total cohort), Additional File 4 (for the female sub-
sample) and Additional File 5 (for the male subsample).
Prevalence of triadic combinations
Combinations of the 46 chronic conditions under study
ranged mainly between 3 and 15 in the mm-sample (see
Figure 1). Further analysis of multimorbidity was based
on combinations of three chronic conditions. In theory,
15,180 such triadic combinations are possible, of which
we found 15,024 (99%) in the dataset. Even for combi-
nations of five conditions we found 832,589 of the theo-
retically possible 1,370,754 (60.7%). Table 2 shows the
10 most prevalent triadic combinations (see Additional
File 6 for full data on the 50 most frequent combina-
tions). The most frequent individual chronic conditions
also dominate the triadic combinations. The highest pre-
valence was found for the combination hypertension,
lipid metabolism disorders and chronic low back pain
(12.1% in the mm-sample and 7.5% in the total cohort).
A closer look at the 10 most frequent combinations
shows that these three conditions, together with diabetes
mellitus, osteoarthritis, and chronic ischemic heart dis-
ease, are the main components of the 10 most prevalent
triads: hypertension was present in 9 out of 10, lipid
metabolism in 6, and chronic low back pain in 5 out of
the top ten prevalent triads. Triads of the six most pre-
valent individual chronic conditions (hypertension, lipid
metabolism disorders, chronic low back pain, diabetes
mellitus, osteoarthritis and chronic ischemic heart dis-
ease) spanned the disease spectrum of 42% of the multi-
morbid sample. Gender differences were minor: All
combinations with osteoarthritis were more prevalent in
females, whereas all combinations with chronic ischemic
heart disease were more prevalent in men. Also, the
combination of hypertension, lipid metabolism disorders
and purine/pyrimidine metabolism disorders/gout was
the fourth most frequent triad in multimorbid males
(prevalence 9.7% in the male mm-sample), whereas this
combination ranked 21st among the most frequent
combinations in women (prevalence 5.9% in the female
mm-sample).
The dominance of a small number of chronic condi-
tions in the combinations is also illustrated by the fact
that hypertension alone is present in two-thirds of the
100 most prevalent triads.
Relative risk for multimorbidity
The relative risk (or risk ratio; RR) expresses the likeli-
hood that a chronic condition will be associated with
multimorbidity in consideration of the prevalence of
that condition. Table 3 lists the chronic conditions with
the highest (cut-off: RR > 15) and the lowest relative
risk (RR < 5) for multimorbidity in the mm-sample
according to gender and age groups.
The risk ratio for multimorbidity was highest for renal
insufficiency (25.5) and obesity (20.3). A risk ratio of
25 means that people with this syndrome are 25 times
more frequently multimorbid than non-multimorbid.
Most chronic conditions had a comparable relative risk
in both genders, whereas some had a much higher one
Figure 2 Mean number of chronic conditions according to age
and gender in the non-multimorbid and the multimorbid
sample. Means were calculated for each year of life until 80. Due to
the small number of cases in old age, we generated four age
groups for age > 80 years before calculation.
Figure 1 Frequency (in %) of the number of chronic conditions
within the list of 46 conditions in the non-multimorbid sample
(light grey columns) and the multimorbid sample (dark grey
columns) and mean and median for both samples.
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Table 2 Adjusted prevalence, prevalence rank order and O/E ratio of the 10 most prevalent triadic combinations of
chronic conditions














Hypertension + lipid metabolism disorders +
chronic low back pain
1 7.5 12.1 11.1 12.6 1
Hypertension + chronic low back pain +
osteoarthritis
2 6.4 10.4 8.1 11.8 1.3
Hypertension + lipid metabolism disorders +
chronic ischemic heart disease
3 5.8 9.4 11.9 7.8 1.2
Hypertension + lipid metabolism disorders +
diabetes mellitus
4 5.8 9.3 10.2 8.7 1,2
Hypertension + lipid metabolism disorders +
osteoarthritis
5 5.4 8.6 6.6 9.9 1
Lipid metabolism disorders + chronic low back
pain + osteoarthritis
6 4.7 7.5 6.1 8.4 1.4
Hypertension + lipid metabolism disorders +
purine/pyrimidine metabolism disorders/gout
7 4.6 7.3 9.7 - 1.6
Hypertension + chronic low back pain +
chronic ischemic heart disease
8 4.5 7.3 8.1 6.8 1
Hypertension + chronic low back pain +
diabetes mellitus
9 4.5 7.3 7.1 7.4 1
Hypertension + diabetes mellitus + chronic
ischemic heart disease
10 4.3 6.9 8.3 6.0 1,3
For adjustment of the prevalences see Additional File 1; rank order according to prevalence in the sample;
mm = multimorbidity
mm-sample = multimorbid sample; O/E ratio = observed-to-expected ratio
Table 3 Chronic conditions with high and with low relative risk for multimorbidity according to gender and age
groups
Diagnosis group RR all RR women RR men RR age 65-74 RR age 75+
High relative risk for multimorbidity
Renal insufficiency 25.5 34.3 23.2 32.6 17.2
Obesity 20.3 19.0 22.1 20.8 26.3
Liver disease 18.1 19.3 17.9 18.4 21.8
Chronic cholecystitis/gallstones 17.8 16.5 19.1 19.5 14.4
Intestinal diverticulosis 17.1 18.8 14.9 16.1 20.0
Urinary tract calculi 16.7 27.0 15.5 17.8 17.9
Purine/pyrimidine metabolism disorders/Gout 16.2 31.4 12.9 15.5 18.2
Atherosclerosis/PAOD 16.1 16.8 16.2 18.0 12.1
Anemia 15.8 17.3 14.5 20.8 10.5
Neuropathy 15.2 14.9 15.6 17.5 11.6
Low relative risk for multimorbidity
Hypertension 3.7 3.4 4.1 3.9 3.2
Dementias 3.9 3.4 4.9 4.6 2.6
Cancers 4.3 4.4 4.5 4.2 4.2
Severe vision reduction 4.5 4.4 4.6 4.5 4.0
RR = risk ratio (or relative risk)
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among women (purine/pyrimidine disorders, urinary
tract calculi and renal insufficiency) (see Additional Files
3, 4, 5 for full data on gender differences). Renal insuffi-
ciency, anaemia and obesity had a risk ratio ≥ 20 among
those aged under 75 years, whereas obesity, liver disease
and intestinal diverticulosis had such a risk ratio in the
age group ≥ 75 years. The risk ratio was lowest for
hypertension (3.7), dementia (3.9), cancer (4.3) and
severe vision reduction (4.5). The risk ratio of dementia
was lower for those aged 75 and older compared to
those aged 65-74, and also much lower for women than
for men.
Observed-to-expected ratio of frequent combinations
We extracted those triadic combinations with an O/E
ratio ≥ 1.5 from the list of the 100 most prevalent com-
binations and found 16 combinations (see Additional
File 6). Such a cutoff score means that the prevalence of
a combination was some 50% higher than expected
based on the prevalence of the individual conditions.
Remarkably, purine/pyrimidine metabolism disorders/
gout was present in 7 of the 16 combinations with high
excess prevalence, and osteoarthritis was present in 6 of
them. It should also be noticed that the majority of
triads with a higher O/E ratio were combinations with a
relatively low prevalence, as only 3 triads in Additional
File 6 belong to the top third of the 100 most prevalent
combinations while all others have a relatively low
prevalence.
This phenomenon is also illustrated by the fact that
only one of the top ten prevalent combinations has a
relatively high O/E ratio: 1.6 for the combination hyper-
tension + lipid metabolism disorders + urine/pyrimidine
metabolism disorders/gout (see Additional File 7).
Discussion
The statutorily insured elderly German population
examined in this study showed a high degree of multi-
morbidity, as 62% of the cohort had 3 chronic condi-
tions or more from a list of 46. This high prevalence
was found in spite of a cut-off score for multimorbidity
that is more selective than in most other studies, which
define multimorbidity as a coexistence of ≥ 2 chronic
conditions [23]. The median of chronic conditions
among the multimorbid was 5, with almost no gender-
related and only small age-related differences. Our
results are in line with those of the few German studies
on multimorbidity in the elderly population. The “Berli-
ner Altersstudie” (Berlin Aging Study - BASE), a repre-
sentative cohort study on aging in Berlin aged 70 to 95+
that was based on extensive clinical examinations and
interviews, found an average prevalence of ≥ 5 chronic
conditions from a list of 28 in 88% of their sample [24].
In 2006 the ADT Panel Study of the German Central
Institute of Statutory Ambulatory Medical Care found
an average of 6 diagnoses in the age group between 60
and 80 visiting a GP [18,19]. Furthermore, the CON-
TENT Study, in which morbidity was continuously
recorded in general practices in 2006 using the Interna-
tional Classification of Primary Care (ICPC), found com-
binations of hypertension, lipid metabolism disorders,
diabetes mellitus, low back pain/osteoarthritis and
chronic ischemic heart disease to be the most frequent
individual conditions in both genders, also including
depression in females [25]. This result matches perfectly
with our findings regarding the constituents of the most
frequent triadic combinations. The results of the study
on multimorbidity published in 2003 by the Robert
Koch Institute - the national epidemiological institute
financed by the federal government - are hardly compar-
able since that study was based mainly on patient survey
data and was limited to the population aged up to
79 years [26]. Our results are also in line with those
from studies in other countries, the majority of which
also reported prevalences of multimorbidity between
50% and nearly 100% in the elderly. For example, in
2005 Britt et al. found a 75% prevalence of multimorbid-
ity in the general practice setting, on the basis of
2 chronic conditions, in a sample of Australians aged
65-74 years, and an 83% prevalence for those aged
80 years and more [4]. In a similar setting in Quebec,
Fortin et al. found a multimorbidity prevalence on the
same basis in 99% of women and in 97% of men for the
age-group 65 and older, and of 98% and 91% respectively
when using the criterion of 3 conditions [5]. According
to Anderson und Horvath, two-thirds of the US popula-
tion aged 65 years and older suffer from at least two
chronic conditions [27], whereas Wolff et al. found that
65% of a Medicare sample had 2 or more, 43% 3 or more,
and 24% 4 or more chronic conditions [28].
The marked differences in prevalence figures are due
to several kinds of differences in study design. They are
related to the population under investigation (e.g. popu-
lation-based versus GP-patient populations) [8] or the
frequency of visits to physicians, particularly specialists.
Differences with regard to the definition and inclusion
of morbidity may even be more important. The syn-
dromes under investigation are usually defined in a
closed list of (chronic) diseases, but the number of
included syndromes varies between a figure less than 10
and more than 100 [8,11,20,23]. In some cases, open
lists are used. The items included are ICD codes (single
or grouped), involved morbidity domains (organs and
systems) within multimorbidity indexes, or causes for
contact with the GP based on the ICPC [25]. An over-
view of methods available for the measurement of
comorbidity and the assessment of their validity and
reliability is provided by de Groot et al. [29]. Also, in
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many studies the analysis is restricted to numbers, leav-
ing the medical impact and the subjective burden out of
scope of investigation, in spite of their relevance from
the patient’s perspective [30]. Other studies include
information on severity and impact on patients [4]. An
important difference is also due to the chosen cut-off
score for multimorbidity. As described earlier, the pre-
sence of ≥ 2 chronic conditions is usually used as a cri-
terion, whereas some use ≥ 3 conditions, especially for
GP-populations [8,21]. In a recent study comparing two
data sources, Fortin et al. found a prevalence of multi-
morbidity around 70% in the age group 65-79 years and
around 90% in the age group ≥ 80 years in a GP-based
sample when using the criterion of ≥ 2 chronic condi-
tions. Using the criterion of ≥ 3 chronic conditions, pre-
valences were much lower (around 45% in the age
group 65-79 years and around 65% in the age group ≥
80 years). Fortin et al. also found a prevalence increase
of around 30% in the age-group 65-79 years when using
an open list of diseases instead of a closed list of seven
diseases (all figures not exactly reported in the paper
but drawn from the figures) [21]. Generally speaking,
the more chronic conditions included, the higher the
prevalence of multimorbidity should be, whereas a
higher cut-off score for multimorbidity (e.g. 3 or 4
instead of 2 chronic conditions) should lead to lower
prevalences. Last but not least, different methods for the
analysis of the co-occurrence of conditions are used [9].
Because of these multiple differences in approach,
research would indeed benefit from a process of agree-
ing upon the methodology and inclusion criteria of
forthcoming studies on multimorbidity [8,21].
The small gender differences with regard to the num-
ber of chronic conditions found in this study are in line
with the results of Britt et al. [4] and van den Akker
et al. [7]. In other studies, however, larger gender differ-
ences were found, usually showing a higher prevalence
in women [10], but occasionally also in men [5,21].
However, important gender differences were found in
this study for individual chronic conditions and combi-
nations: all combinations with osteoarthritis were more
prevalent in women, whereas all combinations with
chronic ischemic heart disease were more prevalent in
men. Also, the prevalence of the combination of hyper-
tension, lipid metabolism disorders and purine/pyrimi-
dine metabolism disorders/gout was much higher in
men than in women.
Beyond counting chronic conditions, this study
attempted to look more closely at the individual diseases
and the development and consequences of (triadic) dis-
ease combinations, their possible interactions and syner-
gies. On the one hand, we identified a small number of
chronic conditions which were involved in the vast
majority of frequent triadic combinations (hypertension,
lipid metabolism disorders, chronic low back pain, dia-
betes mellitus, osteoarthritis, and chronic ischemic heart
disease). On the other hand, we found that 99% of the
possible combinations of three chronic conditions were
indeed present in the data. This means that multimor-
bidity appears in an almost infinite number of variants
with a mostly low prevalence [8], which makes it diffi-
cult to draw generalizable conclusions about the medical
care needs of multimorbid persons. We identified high-
risk ratios for multimorbidity for a certain number of
chronic conditions, either in both genders (e.g. obesity
and renal insufficiency) or more pronounced in women
(e.g. purine/pyrimidine metabolism disorders/gout and
urinary tract calculi; see Additional File 3, 4 and 5). In
our view it is an important result that, in addition to
renal insufficiency, obesity has a high relative risk for
multimorbidity in men and women and throughout all
age groups. This hits upon the need for prevention and
support of patients undertaking lifestyle changes to start
long before the age of 65.
The O/E ratio allowed for the detection of excess pre-
valence not explicable by the mere addition of individual
prevalences. In this respect, purine/pyrimidine metabo-
lism disorders/gout and osteoarthritis in particular
showed excess prevalence in several combinations. Both
conditions should be examined in depth as potential
predictors of multimorbidity in further analyses.
On the other hand, some chronic conditions have a
low degree of association with multimorbidity. In the
case of hypertension, this is due to the fact that hyper-
tension is also frequent in the non-multimorbid popula-
tion. As for dementia, this condition does not appear in
any of the 100 most frequent triadic combinations. The
relative “stand-alone” character of dementia in this
study is in line with the finding by Marengoni et al. in
the Swedish Kungsholmen study, in which dementia had
the highest percentage of cases without comorbidity [9].
As stated by Marengoni, this may be due to an underre-
porting of complaints, such as pain symptoms, by
patients with dementia in clinical examinations. How-
ever, a long-standing relationship with a GP might lead
to another result, as we found that patients with demen-
tia had a significantly higher number of comorbid con-
ditions than controls in German claims data [31].
Our rationale for the investigation of the multimorbid-
ity patterns was formulated by Gijsen et al. in their
review on the causes and consequences of comorbidity
in 2001: “All studies [...] found a significant effect of
comorbidity on mortality, functional status, (and) quality
of life. Here [...], it remains largely unclear to which
extent generalizable influences of multimorbidity or spe-
cific effects of individual disease combinations are
responsible for which effects” [12]. We believe that the
clinical relevance of future studies on multimorbidity
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will depend largely on the investigation of the aetiology,
as well as the course and the impact of specific combi-
nations of chronic conditions [8,21,32].
This study has a number of limitations but also
strengths. We examined a larger spectrum of chronic dis-
eases than most studies. Also, by examining triadic combi-
nations, we approached a more complex spectrum within
multimorbidity. However, as this study is based on claims
data, the diagnoses were not clinically verified by specially
trained professionals. Whereas accidental and erroneous
diagnoses could be minimized by excluding codes appear-
ing in less than three quarters of the year, it cannot be
excluded that physicians differ with regard to coding qual-
ity and thresholds used to qualify a phenomenon as a dis-
ease. We assume that clear-cut somatic conditions suffer
less from underreporting than, for example, conditions
associated with lifestyle, such as obesity or tobacco abuse,
or psychic dysfunction [8]. In an exploratory study com-
paring German claims data with the charts of the GPs in
2003, Erler et al. found an underreporting in 30% of cases
[33]. However, underreporting was related mainly to
minor medical problems, whereas the degree of corre-
spondence for the “classical” chronic conditions requiring
treatment (e.g. diabetes, ischemic heart disease) was high.
Privately insured patients (some 10% of the population)
were not included in this study. It should also be noted
that the prevalence estimates for multimorbidity in this
paper are biased by underreporting due to the fact that a
person can have other chronic conditions than the 46 on
our list. This assumption is supported by the preliminary
findings of our MultiCare prospective multicentre cohort
study based on physician chart reviews and interviews
using an open list. Here, in general, higher prevalences of
multimorbidity were detected [24].
On the other hand, our insurance claims data allow
analyses of large populations over time, including those
living in nursing homes and thus also frail individuals as
well as the oldest of the elderly, who are all frequently
excluded in field studies. The same applies to the lack
of selection bias with regard to the service providers, an
even greater problem in field research. Furthermore,
recall bias and social desirability problems in surveys
and interviews are excluded. Also, the morbidity figures
in our study are not biased by differences in the fre-
quency of health services utilization, as all persons
included visited a physician during at least three quar-
ters of the year [16]. We also used a relatively long list
of chronic conditions, permitting us to include all
chronic conditions with a ≥ 1% prevalence, and thus
minimizing the bias effect caused by including only high
prevalence conditions [20]. To summarize, this is a
descriptive, cross-sectional study with limited possibili-
ties of attribution of causalities in the field of multimor-
bidity. We intend to validate our results by using a
longitudinal approach in the analysis of the claims data
and by comparing the results with those from the Multi-
Care prospective multicentre cohort study, which is
based on chart reviews and structured interviews with
GPs and patients [34].
Conclusion
There is widespread agreement in the literature that
research on multimorbidity should aid in developing
specific guidelines for those suffering from multiple
chronic conditions. Triads of the six most prevalent
individual chronic conditions (hypertension, lipid meta-
bolism disorders, chronic low back pain, diabetes melli-
tus, osteoarthritis, and chronic ischemic heart disease)
correspond to the multimorbidity spectrum of almost
half of the multimorbid sample. We propose to use this
result as a pragmatic starting point for guideline devel-
opment in multimorbidity.
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